Smashing the Stigma with Science

Cannabis can be a turn off for investors, but Neil Mahapatra and his investment firm are showing the world that there’s nothing to fear – and much to potentially gain – through a collaboration with Oxford University.

A Career in Cannabinoids Cannabis Complex Smashing the Stigma with Science A View From the Biosynthetic Bridge Forming a Society for Cannabinoids Enhancing Endocannabinoid Signalling

About the Author(s)

Neil Mahapatra

Neil Mahapatra is Managing Partner of UK investment firm Kingsley Capital Partners, which established Oxford Cannabinoid Technologies in conjunction with a large-scale research programme with Oxford University.

Stephanie Vine

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

Smashing the Stigma with Science

About the Author(s)

Neil Mahapatra

Stephanie Vine

Recommended

What Trump’s Latest Moves Mean for the Industry

Big Bad Pharma?

Access All Areas

Care to ‘Patent Dance’?

Explore

Featured Topics

Issues

Topics

News & Blogs

Community & Awards

Smashing the Stigma with Science

Newsletters

About the Author(s)

Neil Mahapatra

Stephanie Vine

Recommended

Related Content

What Trump’s Latest Moves Mean for the Industry

Big Bad Pharma?

Access All Areas

Care to ‘Patent Dance’?